AI Proteins is a biotechnology company that focuses on the de novo design and engineering of miniprotein therapeutics.
AI Proteins has raised $41.5M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
AI Proteins's investors include Sante Ventures, Mission BioCapital, Lightchain Capital, Intel Ignite, Cobro Ventures.
AI Proteins is headquartered in Boston, United States.
AI Proteins is a biotechnology company that focuses on the de novo design and engineering of miniprotein therapeutics.
AI Proteins is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AI Proteins — Funding & Investors." VCBacked, November 19, 2025, https://www.vcbacked.co/company/ai-proteins. Accessed July 26, 2026.
VCBacked. (2025). AI Proteins — Funding & Investors. Retrieved July 26, 2026, from https://www.vcbacked.co/company/ai-proteins
{{cite web |title=AI Proteins — Funding & Investors |url=https://www.vcbacked.co/company/ai-proteins |website=VCBacked |access-date=July 26, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated